Athens Medical Centre (FRA:ACS) Tariff Resilience Score: 0/10 (As of Jul. 04, 2026)


FRA:ACS Athens Medical Centre SA FRA:ACS
69 GF Score
Price €1.61
GF Value €1.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre Tariff Resilience Score?

Athens Medical Centre has the Tariff Resilience Score of 0, which implies that the company might have .

Athens Medical Centre has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Athens Medical Centre might have .


Athens Medical Centre  (FRA:ACS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Athens Medical Centre Tariff Resilience Score Related Terms

FRA:ACS
69GF Score
Athens Medical Centre SA FRA:ACS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.61 is trading 6.7% below its estimated GF Value™ of €1.72. GuruFocus considers Athens Medical Centre to be Fairly Valued.

Key valuation signals for FRA:ACS:

  • Tariff Resilience Score: 0
  • GF Value™: €1.72 vs. price of €1.61 (6.7% below fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Athens Medical Centre Business Description

Other Exchanges IATR:Greece
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
69GF Score

Get the complete analysis for FRA:ACS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.61
Price
€1.72
GF Value